esmo.orgEuropean Society for Medical Oncology

Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly. MINIMAL Requirements: Google Chrome 24+ , Mozilla Firefox 20+ , Internet Explorer 11 , Opera 15–18 , Apple Safari 7 , SeaMonkey 2.15-2.23 ESMO OncologyPRO 30k 49k 5.5k 30k 7k Login Search Search COVID-19 and Cancer COVID-19 Vaccination COVID-19 Full Coverage News in COVID-19 ESMO Live Roundtables ESMO Facebook Roundtable: COVID-19 Vaccines and Cancer Care - The known, the unknown and the unknowable ESMO Facebook Roundtable: COVID-19 vs Cancer - Reorganising cancer care after the first wave ESMO Facebook Roundtable: COVID-19 vs Cancer - The future of cancer research ESMO Facebook Roundtable: COVID-19 vs Cancer - Weighing up risks over time COVID-19 Useful Resources Elsevier resource centre on COVID-19 KOLs Experiences & Perspectives Registries, Studies and Surveys ESMO-CoCARE Registry COVID-19 Resource Centre Cancer Patient Management During the COVID-19 Pandemic Cancer Care During the COVID-19 Pandemic COVID-19 Palliative Care Pathways COVID-19 and cancer care in the ESMO journals Q&A on COVID-19 About ESMO ESMO Vision 2025 One Oncology Community From ESMO Vision 2020 to ESMO Vision 2025 Integrated Cancer Care Specialised Education Sustainable Cancer Care ESMO Mission ESMO Values Awards ESMO Award Nominations ESMO Award ESMO Award for Translational Research ESMO Women for Oncology Award ESMO Lifetime Achievement Award ESMO Breast Cancer Award Heine H. Hansen Award ESMO Award for Immuno-Oncology TAT Honorary Award Organisational Structure ESMO Council Executive Board Annals of Oncology Editorial Board Audit Committee Cancer Medicines Committee Compliance Committee Global Policy Committee Major Achievements ESMO Open Editorial Board Educational Committee Adolescents and Young Adults Working Group ESMO SIOG Cancer in the Elderly Working Group Practising Oncologists Working Group OncologyPRO Working Group Examination & Accreditation Working Group ESMO Faculty Educational Publications Working Group Translational Research and Precision Medicine Working Group Guidelines Committee Magnitude of Clinical Benefit Scale Working Group Major Achievements Membership Committee National Societies Committee Nomination Committee Press and Media Affairs Committee and Social Media Working Group European Policy Committee Major Achievements Patient Advocates Working Group Young Oncologists Committee Would You Like to Join the Young Oncologists Committee? Major Achievements Fellowship Committee Major Achievements Women for Oncology Committee IOTECH Editorial Board ESMO Faculty ESMO Members: Get Involved ESMO Committees: Application Form How we work Declaration of Interest EFPIA Disclosure Code ESMO Elections Elections 2019: FAQ ESMO Structure Code of Conduct ESMO Funding 2019 Funding Sources ESMO Bylaws General Assembly Discover ESMO Journals Annals of Oncology About Annals of Oncology ESMO Open Frequently Asked Questions Immuno-Oncology and Technology Careers at ESMO ESMO Brand ESMO Logo Collaborate with ESMO Frequently Asked Questions President's Letter Joining Forces ESMO for World Cancer Day 2021 ESMO for World Cancer Day 2020 Contact Us Membership Join ESMO Member Benefits Membership Categories & Annual Fees ESMO in Your Country ESMO Booth Guidelines Cancer Patient Management During the COVID-19 Pandemic Disclaimer Primary brain tumours in the COVID-19 era Gastrointestinal cancers: Hepatocellular carcinoma (HCC) in the COVID-19 era Genitourinary cancers: Urothelial cancer of the bladder in the COVID-19 era Genitourinary cancers: Renal cell cancer in the COVID-19 era Genitourinary cancers: Prostate cancer in the COVID-19 era Gynaecological malignancies: Cervical cancer in the COVID-19 era Gynaecological malignancies: Endometrial cancer in the COVID-19 era Haematological malignancies: DLBCL, MCL and Aggressive T-cell lymphoma in the second phase of the COVID-19 pandemic (ESMO-EHA) Haematological malignancies: Hodgkin lymphoma in the second phase of the COVID-19 pandemic (ESMO-EHA) Haematological malignancies: Indolent B-NHL in the second phase of the COVID-19 pandemic (ESMO-EHA) Haematological malignancies: Multiple myeloma in the COVID-19 era Head and neck cancers in the COVID-19 era Melanoma in the COVID-19 era Sarcomas in the COVID-19 era Supportive Care in the COVID-19 era COVID-19 adapted recommendations Slide Sets Breast Cancer Cancers of Unknown Primary Site Endocrine and Neuroendocrine Cancers Gastrointestinal Cancers Genitourinary Cancers Gynaecological Cancers Gynaecological malignancies: Cervical cancer in the COVID-19 era Gynaecological malignancies: Endometrial cancer in the COVID-19 era Haematological Malignancies Head and Neck Cancers Hereditary Syndromes Lung and Chest Tumours Melanoma Neuro-Oncology Sarcoma and GIST Supportive and Palliative Care Guidelines News ESMO-MCBS ESMO-MCBS and the WHO ESMO-MCBS sessions at ESMO 2020 Articles Scale Evaluation Forms v1.0 & v1.1 Presentations ESMO-MCBS Scorecards Guidelines Slide Sets Pocket Guidelines & Mobile App ESMO Guidelines Methodology Meetings About ESMO Meetings ESMO Congresses ESMO Virtual Plenaries Abstracts Sponsors FAQs ESMO Academy ESMO Advanced Courses FAQs Acknowledgements Testimonials Preceptorship Courses Acknowledgements FAQs Testimonials ESMO Summits Testimonials ESMO-ESO Courses on Medical Oncology for Medical Students ESMO Best Student Award Testimonials ESO-ESMO Masterclasses ESMO Symposia ESMO Colloquia ESMO Colloquia Past ESMO Colloquia ESMO Webinar Series ESMO Guidelines: Real World Cases - Webinar Series SARS-CoV-2 Vaccination: Special Considerations in Patients with Cancer Will Recent Major Trials With CDK Inhibitors Be Practice Changing In Early Breast Cancer? Testing and Targeting Tumours with RET Alterations CDK 4-6 Inhibitors in Breast Cancer Managing Patients in the COVID-19 Era Immune Checkpoint Inhibitors in HNSCC: Changing the Treatment Landscape Translating Immunity to Clinical Applications of Immunotherapy in Breast Cancer Workshops & Courses ESMO Events App Oncology Meetings Calendar Past Meetings Past ESMO Partnership, Labelled and Supported Meetings Career Development Oncology Fellowships Resilience Task Force Young Oncologists Corner ESMO Examination Recertification & CME Jobs in Oncology Women for Oncology Leaders Generation Programme Leaders Generation Programme Asia Leadership Generation Task Force Global Curriculum in Medical Oncology Travel Grants for ESMO Meetings About Career Development Research About the Grant Schemes ESMO Clinical Research Observatory Task Force (ECRO) Acknowledgements: Rationalizing Bureaucracy Bibliography on Clinical Trial Procedures Research Funding opportunities ESMO Webinar: EU Research Opportunities How to Apply For EU Grants EU Calls for Proposal Training and Events Regulatory Information Other Research Funding Opportunities Research Groups, Tools and Database General research groups Cancer research groups by type Databases Research tools For patients Resources for Cancer Patients ESMO Designated Centres of Integrated Oncology & Palliative Care 2020 ESMO Designated Centres Palliative and Supportive Care Sessions at ESMO Asia Virtual Congress 2020 Patient Advocates Working Group Patient Guides Patient Guides by Language Cancer Care During the COVID-19 Pandemic Immunotherapy Side Effects Survivorship Cancer Pain Management Personalised Cancer Medicine Personalised Medicine Explained Patient Advocacy Track Getting the Most out of Your Oncologist Policy ESMO Public Policy Webinars The General Data Protection Regulation Bedside Rationing Europe’s Beating Cancer Plan – in 60 minutes ESMO Call to Action on COVID-19 Vaccinations and Patients with Cancer: Vaccinate. Monitor. Educate. ESMO Call to Action on COVID-19 Vaccinations and Patients with Cancer: Vaccinate. Monitor. Educate. Policy News Cancer Prevention Portal Science IARC World Cancer Report Updates Learning Platform and Webinars Educa...